TWA
ALDR

TCI Wealth Advisors’s Alder Biopharmaceuticals ALDR Stock Holding History

TCI Wealth Advisors’s Portfolio ALDR Stock Details ALDR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-26
Closed -$1K – 1426
2016
Q4 		$1K Hold
26
– – ﹤0.01% 1303
2016
Q3 		$1K Hold
26
– – ﹤0.01% 1295
2016
Q2 		$1K Buy
+26
New +$703 ﹤0.01% 1228

Other funds holding ALDR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BB
BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return
FCMI
Foresite Capital Management III Larkspur, California $37.9M AUM 6.87% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

TCI Wealth Advisors's ALDR Position: Q1 2017 in Review

TCI Wealth Advisors sold out of Alder Biopharmaceuticals (ALDR) in Q1 2017, closing a stake of 26 shares — an estimated $1K sold.

TCI Wealth Advisors first reported a position in ALDR in Q2 2016 and held it in 3 quarters. The position peaked at $1K in Q4 2016. 142 funds tracked by Wall St. Rank hold ALDR as of Q1 2017.

  • TCI Wealth Advisors reported no remaining Alder Biopharmaceuticals position as of Q1 2017 after selling out during the quarter.
  • TCI Wealth Advisors sold 26 Alder Biopharmaceuticals shares in Q1 2017, an estimated $1K.
  • TCI Wealth Advisors first reported a position in Alder Biopharmaceuticals in Q2 2016 and held it in 3 quarters.
  • TCI Wealth Advisors's Alder Biopharmaceuticals position peaked at $1K in Q4 2016.
  • 142 funds tracked by Wall St. Rank held Alder Biopharmaceuticals as of Q1 2017.

Based on TCI Wealth Advisors's 13F filing for Q1 2017, filed 4 May 2017.